Will sales of ‘Enbrel’ increase by the launch of its biosimilar?

Published: 2016-03-17 16:37:25

Updated: 2016-03-17 16:37:25

The launch of biosimilar ‘Brenzys’ decreased the health insurance benefit of ‘Enbrel’ by 30%, enlarging the price competition against Enbrel. Their prescriptions will be increased jointly through the effect of the launch and the ‘cost-effectiveness’ of Enbrel.

From February of this year, the Enbrel’s health insurance price dropped by 30% due to the Brenzys launch.

The 4-week injection of En...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.